Dr. Hopp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
Milwaukee, WI 53226Phone+1 414-805-6600Fax+1 414-805-6622
Education & Training
Medical College of Wisconsin Affiliated HospitalsResidency, Obstetrics and Gynecology, 2012 - 2016- Medical College of WisconsinClass of 2012
Certifications & Licensure
OH State Medical License 2014 - 2026
WI State Medical License 2013 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors Start of enrollment: 2024 Feb 08
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial.Jyoti Mayadev, Dmitriy Zamarin, Wei Deng, Heather A Lankes, Giulio Pesci
Nature Communications. 2025-01-09 - Landscape of potential germline pathogenic variants in select cancer susceptibility genes in patients with adult-type ovarian granulosa cell tumors.Rebekah M Summey, Erica Gornstein, Brennan Decker, Kali C Dougherty, Janet S Rader
Cancer Medicine. 2024-06-01 - 1 citationsCarboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer.Denise Uyar, Chad M Michener, Erin Bishop, Elizabeth Hopp, Pippa Simpson
Frontiers in Oncology. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
